Working together to accelerate patient access to advanced therapies
Our network
Coordinated by Cell and Gene Therapy Catapult
iMATCH is a regional consortium (currently covering Greater Manchester and Sheffield) that focuses on the scale-up of ATMP activity within the NHS. We work to maximise patient access to ATMPs, whilst ensuring safe and efficient delivery.
The Midlands and Wales Advanced Therapy Treatment Centre (MW-ATTC) consists of a large regional network. The centre includes a wide range of specialists in advanced therapies.
NA-ATTC is a consortium currently covering North-East England and Scotland that focuses on the development of systems and infrastructure required to support the delivery of cell and gene therapies.
LAT-ATTC (London Advanced Therapies) is a London-born consortium focused on development of the systems and infrastructure required to support the delivery, and improving access to ATMPs for patients. The centre includes a wide range of specialists in advanced therapies.
